In the second study, significant
reductions in placebo-adjusted least square means for
the glucose (mg/dL) area under the curve were seen in the
9 mg, 16 mg, and 32 mg albiglutide groups at days 2 and 9.
Postprandial glucose reductions were similar.15,16